Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies

Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies

<b>Background:</b> Recombinant tissue plasminogen activator (rtPA) remains the standard thrombolytic treatment for ischemic stroke. Different types of nanoparticles have emerged as promising tools to improve the benefits and decrease the drawbacks of this therapy. Among them, cell membra...

Full description

Saved in:
Bibliographic Details
Main Authors: Jesús Prego-Domínguez, Fernando Laso-García, Nuria Palomar-Alonso, María Pérez-Mato, Esteban López-Arias, Antonio Dopico-López, Pablo Hervella, María Gutiérrez-Fernández, María Alonso de Leciñana, Ester Polo, Beatriz Pelaz, Pablo del Pino, Francisco Campos, Clara Correa-Paz
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceutics
Subjects:
cell membrane-derived nanomedicines
ischemic stroke
meta-analysis
nanoparticles
rtPA
thrombolysis
Online Access:https://www.mdpi.com/1999-4923/17/2/208
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items